Search Results 11-20 of 11394 for anti-TNF drugs

  1. A Study To Assess Change In Disease Activity And Adverse Events Of Oral Upadacitinib In Adult And Adolescent Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug for ulcerative ...

  2. Medicines that treat ulcerative colitis - Mayo Clinic

    Anti-TNF agents: TNF blockers. This type of biologic medicine helps calm ulcerative colitis by blocking the actions of an immune system protein called tumor ...

  3. Crohn's Disease Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  4. Medicines that treat ulcerative colitis - Mayo Clinic

    Anti-inflammatory medications · Aminosalicylates · Corticosteroids ; Biologic medicines · Anti-TNF agents: TNF blockers · Interleukin‑12 and interleukin‑23 pathway ...

  5. Crohn's Disease Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  6. Crohn's Disease Surgery Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  7. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    These include tumor necrosis factor-alpha (TNFα) inhibitors (certolizumab, infliximab, adalimumab), anti-integrin agents (vedolizumab, natalizumab), and ...

  8. A Study To Assess Change In Disease Activity And Adverse Events Of Oral Upadacitinib In Adult And Adolescent Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug for ulcerative ...

  9. Crohn's Disease Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  10. Psoriatic arthritis - Diagnosis & treatment - Mayo Clinic

    Biologic DMARDs, called biologics. These newer drugs target specific parts of the immune system that cause joint inflammation. The medicines include adalimumab ...